Abacus Global Management Responds To Misleading Short Report; Says Abacus Will Be Producing A More Detailed Response To The Inaccurate And False Claims Made By The Short Seller In The Coming Days.
Abacus Life, Inc. - Class A Common Stock ABL | 0.00 |
Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a leader in the alternative asset management space, today provided the following response to a false and misleading short attack.
Abacus has been buying and selling life insurance policies for over two decades with long-standing and trusted counter-party relationships. If Abacus used flawed data causing over-valuation of the underlying insurance product assets, the Company would be going out of business, not consistently producing positive realized returns. As highlighted in the first quarter 10-Q Abacus filed on May 8, 2025, Abacus realized gains of nearly 40% while deploying capital of 126 million. These realized gains were within a margin of error of 2% of the mark from the prior quarter.
Recommend
- Simply Wall St 19/11 18:27
Is Clover Health (CLOV) Undervalued After Recent Share Price Decline?
Simply Wall St 19/11 19:22Don't Ignore The Insider Selling In Primerica
Simply Wall St 20/11 11:11How Does Corebridge Financial’s (CRBG) $500M Preferred Offering Reflect Its Capital Allocation Priorities?
Simply Wall St 20/11 16:15Everest Group Appoints Elias Habayeb Group CFO, Effective Around May 1, 2026, Succeeding Mark Kociancic
Benzinga News 20/11 21:17Oscar Health (OSCR): Assessing Valuation After New Tech-Driven Plans and Q3 Earnings Reveal
Simply Wall St 20/11 21:27A Look at F&G Annuities & Life's (FG) Valuation After Its Latest Dividend Boost
Simply Wall St Today 01:29Aflac (AFL): Assessing Valuation Following Board-Approved Dividend Increase
Simply Wall St Today 10:23


